SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration
Shares of Rivian have been rallying after the company posted better-than-expected results. It also held an event highlighting its artificial intelligence (AI) efforts.
Adagene jumps 13.8% after the FDA grants Fast Track Status to muzastotug with pembrolizumab for MSS metastatic colorectal cancer.
Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions and fill an unmet need
Union Pacific maintains a 'Buy' rating, supported by strong Q3 2025 results and reaffirmed high single-digit to low double-digit EPS growth guidance. UNP's operational excellence is evident with a 58.
KYMR gains momentum as the FDA grants Fast Track to KT-621 for moderate to severe atopic dermatitis, boosting the stock and advancing its Type 2 pipeline.
Highly concerning nominee backgrounds underscore questionable judgment by Edward Smolyansky and George Sent, Managing Director of Cascadia Capital
LONDON--(BUSINESS WIRE)-- #AmazonPrime--YouTube TV is set to redefine the US television landscape. According to new forecasts from Omdia, YouTube TV will surpass Charter and Comcast to become the larg

Cisco Stock on Track for Highest Close Since 2000

03:32pm, Wednesday, 10'th Dec 2025
Cisco stock was on pace to close at a record high for the first time since March 27, 2000.
PHILADELPHIA and VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage bio
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety profile comparable to 1500mg QW dose, further derisking pivotal FORTIFI-HN01 study i
Victoria's Secret & Co. delivered a strong Q3 beat and raised full-year guidance, signaling a turnaround in performance. Net sales grew 9% year-over-year to $1.472 billion, with comparable sales up 8%
Despite November's volatility, optimism is returning to Wall Street. Discover how long-term strategies combined with ETFs can help investors build resilient portfolios ready to capture the next phase
Highly concerning nominee backgrounds underscore questionable judgement by Edward Smolyansky and George Sent, Managing Director of Cascadia Capital
RICHMOND, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE